56612-14-7 Usage
Uses
Used in Pharmaceutical Development:
N-[(tert-Butoxy)carbonyl]-N-methylglycyl-N-methylglycine is used as a building block in the synthesis of peptide-based drugs for its potential to contribute to the development of new pharmaceuticals.
Used in Chemical Research:
N-[(tert-Butoxy)carbonyl]-N-methylglycyl-N-methylglycine is employed in the study of organic reactions, aiding in the understanding and advancement of chemical processes and mechanisms.
Used in the Preparation of Novel Chemical Compounds:
N-[(tert-Butoxy)carbonyl]-N-methylglycyl-N-methylglycine is utilized in the preparation of new chemical compounds, expanding the scope of chemical diversity and potential applications.
Used in Bioconjugation:
In the field of bioconjugation, N-[(tert-Butoxy)carbonyl]-N-methylglycyl-N-methylglycine is used for its specific structure and properties, which allow for the attachment of biologically active molecules to other entities, enhancing their functionality.
Used in Drug Delivery Systems:
N-[(tert-Butoxy)carbonyl]-N-methylglycyl-N-methylglycine is applied in drug delivery systems to improve the efficiency and targeting of therapeutic agents, leveraging its unique structural attributes for controlled release or specific interactions with biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 56612-14-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,1 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56612-14:
(7*5)+(6*6)+(5*6)+(4*1)+(3*2)+(2*1)+(1*4)=117
117 % 10 = 7
So 56612-14-7 is a valid CAS Registry Number.
56612-14-7Relevant academic research and scientific papers
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
-
, (2012/12/14)
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS
-
Page/Page column 217, (2008/06/13)
The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
